Toni Clarke – Page 4 –

Study questions FDA’s shorter drug approval times

August 24, 2021 at 4:51 p.m.

WASHINGTON (Reuters) - New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are...

Study questions FDA’s shorter drug approval times

May 14, 2019 at 12:19 a.m.

WASHINGTON (Reuters) - New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are...

FDA advisory panel chair pulls out of conference amid ethics flap

August 24, 2021 at 4:45 p.m.

WASHINGTON (Reuters) - The chairwoman of an advisory panel to the U.S. Food and Drug Administration said she will withdraw from a drug industry conference after the consumer rights group...

FDA recommends tightening access to hydrocodone painkillers

August 24, 2021 at 4:49 p.m.

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such...

FDA advisory panel chair pulls out of conference amid ethics flap

May 14, 2019 at 1:35 a.m.

WASHINGTON (Reuters) - The chairwoman of an advisory panel to the U.S. Food and Drug Administration said she will withdraw from a drug industry conference after the consumer rights group...

FDA recommends tightening access to hydrocodone painkillers

May 14, 2019 at 12:19 a.m.

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such...

U.S. FDA panel backs Paladin Labs’ parasitic disease drug

August 24, 2021 at 4:35 p.m.

(Reuters) - Paladin Labs Inc's experimental drug to treat a rare parasitic disease is effective and safe enough to be approved, an advisory panel to the U.S. Food and Drug...

U.S. FDA panel backs Paladin Labs’ parasitic disease drug

May 14, 2019 at 12:17 a.m.

(Reuters) - Paladin Labs Inc's experimental drug to treat a rare parasitic disease is effective and safe enough to be approved, an advisory panel to the U.S. Food and Drug...

Factbox: Who could take over from Janet Woodcock at FDA’s drugs division?

August 24, 2021 at 4:15 p.m.

WASHINGTON (Reuters) - The retirement of Dr. Janet Woodcock as head of the Food and Drug Administration's pharmaceutical division is at least a year away, but the industry she regulates...

Insight: Big Pharma braces for retirement of favorite regulator

August 24, 2021 at 4:11 p.m.

WASHINGTON (Reuters) - The retirement of Dr. Janet Woodcock as head of the Food and Drug Administration's pharmaceutical division is at least a year away, but already the industry she...

All Stories